Drug profile

The FDA adverse-event record for Amoxicillin Trihydrate / Potassium Clavulanate

15 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Amoxicillin Trihydrate / Potassium Clavulanate. See the species affected, top reactions, and outcomes below.

15
adverse-event reports
6.7%
death-coded share
Unknown
most-reported species
8
Tablets, Abnormal - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
1
Deaths Reported
6.7%
Death Rate

Active Ingredients

Amoxicillin Trihydrate / Potassium Clavulanate

Administration Routes

UnknownOral

Species Affected

Unknown 8
Dog 7

Most Affected Breeds

Unknown 8
American Pit Bull Terrier 2
Terrier - Cairn 1
Bichon Frise 1
Dog (other) 1
Terrier - West Highland White 1
Spaniel - King Charles Cavalier 1

Most Reported Reactions

Tablets, Abnormal 8
Contamination, Foreign Object 4
Contamination NOS 4
Laboured breathing 2
Tachypnoea 2
Pneumonia 2
Anorexia 2
Haematuria 1
Proteinuria 1
Death by euthanasia 1
Vomiting 1
Discomfort NOS 1

Outcome Breakdown

Outcome Unknown
3 (42.9%)
Recovered/Normal
3 (42.9%)
Euthanized
1 (14.3%)

Amoxicillin Trihydrate / Potassium Clavulanate Adverse Event Insights

15 reports name Amoxicillin Trihydrate / Potassium Clavulanate; 1 recorded a death outcome (6.7% of reported events, not a population-level mortality rate). Active ingredient: Amoxicillin Trihydrate / Potassium Clavulanate. Administration routes: Unknown, Oral.

By species: Unknown (8 reports), Dog (7 reports). By breed: Unknown (8), American Pit Bull Terrier (2), Terrier - Cairn (1).

Leading clinical signs: Tablets, Abnormal (8), Contamination, Foreign Object (4), Contamination NOS (4), Laboured breathing (2). Outcome, 7 coded reports: Outcome Unknown leads at 42.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.